Publication date: Feb 05, 2025
The number of patients experiencing re-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is progressively increasing. In this study, we aimed to explore the differences in clinical characteristics between patients with primary infection and those with re-infection of SARS-CoV-2. A retrospective data analysis was conducted involving patients diagnosed with coronavirus disease 2019 between April 1, 2023, and June 20, 2023. The patients were categorized into two groups: the observation group, consisting of individuals re-infected with SARS-CoV-2, and the control group, comprising those with primary SARS-CoV-2 infection. A total of 905 (905/1025) patients were included in the study, with 407 in the observation group and 498 in the control group. The top three clinical symptoms in both groups were fever, cough with expectoration, and dizziness with fatigue (p
Open Access PDF
| Concepts | Keywords |
|---|---|
| China | Clinical characteristics |
| Coronavirus | Omicron variant |
| Fatigue | Reinfection |
| SARS-CoV-2 |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | reinfection |
| disease | IDO | primary infection |
| disease | MESH | coronavirus disease 2019 |
| pathway | REACTOME | SARS-CoV-2 Infection |
| pathway | REACTOME | Reproduction |
| disease | MESH | Infectious Diseases |
| drug | DRUGBANK | (S)-Des-Me-Ampa |
| drug | DRUGBANK | Coenzyme M |
| disease | IDO | symptom |